Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元，同比增加27.43%

市场透视11-23

11月23日，Hookipa Pharma Inc.（HOOK.US）公布财报，公告显示公司2024财年第三财季净利润为-13.84百万美元，同比增加27.43%；其中营业收入为4.70百万美元，同比减少31.59%，每股基本收益为-1.10美元。从资产负债表来看，Hookipa Pharma Inc.（HOOK.US）总负债37.93百万美元，其中短期债务1.21百万美元，资产负债比为0.03，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2485982702?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-23 00:03","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2485982702","market":"us","top_or_hot":-1,"title":"Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元，同比增加27.43%","media":"市场透视","content":"<div>\n<p>11月23日，Hookipa Pharma Inc.（HOOK.US）公布财报，公告显示公司2024财年第三财季净利润为-13.84百万美元，同比增加27.43%；其中营业收入为4.70百万美元，同比减少31.59%，每股基本收益为-1.10美元。从资产负债表来看，Hookipa Pharma Inc.（HOOK.US）总负债37.93百万美元，其中短期债务1.21百万美元，资产负债比为0.03，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元，同比增加27.43%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHookipa Pharma Inc.2024财年第三财季实现净利润-13.84百万美元，同比增加27.43%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-23 00:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月23日，Hookipa Pharma Inc.（HOOK.US）公布财报，公告显示公司2024财年第三财季净利润为-13.84百万美元，同比增加27.43%；其中营业收入为4.70百万美元，同比减少31.59%，每股基本收益为-1.10美元。从资产负债表来看，Hookipa Pharma Inc.（HOOK.US）总负债37.93百万美元，其中短期债务1.21百万美元，资产负债比为0.03，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HOOK","symbol_name":"Hookipa Pharma Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b","article_id":"2485982702","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2485982702","pubTimestamp":1732291407,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月23日，Hookipa Pharma Inc.公布财报，公告显示公司2024财年第三财季净利润为-13.84百万美元，同比增加27.43%；其中营业收入为4.70百万美元，同比减少31.59%，每股基本收益为-1.10美元。从资产负债表来看，Hookipa Pharma Inc.总负债37.93百万美元，其中短期债务1.21百万美元，资产负债比为0.03，流动比率为3.27。机构评级：截至2024年11月23日，当前有4家机构对Hookipa Pharma Inc.目标价做出预测，其中目标均价为36.25美元，其中最低目标价为7.00美元，最高目标价为50.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"HOOK":"Hookipa Pharma Inc"},"translate_title":"Hookipa Pharma Inc. achieved net profit of-US $13.84 million in the third fiscal quarter of fiscal year 2024, a year-on-year increase of 27.43%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOOK":1},"content_text":"11月23日，Hookipa Pharma Inc.（HOOK.US）公布财报，公告显示公司2024财年第三财季净利润为-13.84百万美元，同比增加27.43%；其中营业收入为4.70百万美元，同比减少31.59%，每股基本收益为-1.10美元。从资产负债表来看，Hookipa Pharma Inc.（HOOK.US）总负债37.93百万美元，其中短期债务1.21百万美元，资产负债比为0.03，流动比率为3.27。机构评级：截至2024年11月23日，当前有4家机构对Hookipa Pharma Inc.目标价做出预测，其中目标均价为36.25美元，其中最低目标价为7.00美元，最高目标价为50.00美元。公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。 它使用现成的技术VaxWave和TheraT直接在患者体内引发抗原特异性杀伤性T细胞和抗体的应答。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485982702"}